| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 3GFS72WN4M |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Neuroblastoma | Phase 2 | ClinicalTrials |
| Neuroblastoma | Phase 2 | ClinicalTrials |
| Neuroblastoma | Phase 1 | ClinicalTrials |
| Neuroblastoma | Phase 1 | ClinicalTrials |
| Neuroblastoma | Phase 1 | ClinicalTrials |
| Neuroblastoma | Phase 2 | ClinicalTrials |
| Neuroblastoma | Phase 2 | ClinicalTrials |
| Neuroblastoma | Phase 2 | ClinicalTrials |
| Neuroblastoma | Phase 2 | ClinicalTrials |
| Neuroblastoma | Phase 2 | ClinicalTrials |
| Neuroblastoma | Phase 2 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109418 |
| FDA SRS | 3GFS72WN4M |
CONTENTS